Ocular toxicity of tamoxifen.
Tamoxifen is an antioestrogen drug used widely in the management of oestrogen-dependent metastatic breast carcinoma. A number of ocular complications have been described secondary to tamoxifen therapy. We report two patients, one of whom had superior ophthalmic vein thrombosis and the other who had painful proptosis and acute angle-closure glaucoma with choroidal detachment secondary to tamoxifen therapy, both of which have not been reported earlier. In both patients the signs and symptoms resolved rapidly after the discontinuation of tamoxifen therapy. Awareness of the ocular toxicity of tamoxifen is essential as prompt withdrawal can result in resolution of most of the complications.
L.V. Prasad Eye Institute, Hyderabad.
G C
GC
Sekhar
R
R
Nagarajan
D000208:Acute Disease; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D015862:Choroid Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D005094:Exophthalmos / Q000139:chemically induced*; D005260:Female; D015812:Glaucoma, Angle-Closure / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D009915:Orbit / Q000098:blood supply*; D013629:Tamoxifen / Q000009:adverse effects*; D013924:Thrombophlebitis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography; D014680:Veins
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen